Alliance Global Partners reissued their buy rating on ... The company’s lead product is IGC-AD1, which is in a Phase 2B clinical trial as a treatment for agitation in dementia due to Alzheimer ...

POTOMAC, MD / ACCESS Newswire / March 4, 2025 / IGC Pharma, Inc. ("IGC" or the "Company") today announced an advancement in its Artificial Intelligence ("AI") platform with the development of a new AI ...

IGC Pharma Announces Equity Analyst Update by Alliance Global Partners (AGP ... an expansion of its clinical research program for IGC-AD1, an investigational treatment for Alzheimer's disease.

Long-Term Safety of Ruxolitinib Cream in Adults and Adolescents with Mild-to-Moderate Atopic Dermatitis: Adverse Events of Interest from the TRuE-AD1 and TRuE-AD2 Phase ... About Incyte A global ...

"The third quarter of fiscal 2025 was marked by our progress in advancing IGC-AD1 in our Phase 2 CALMA trial aimed at reducing agitation in Alzheimer's," said Mr. Ram Mukunda, CEO. "We are also ...

Two posters presented at the 2025 American Academy of Dermatology Annual Meeting reaffirmed the impact of ruxolitinib cream ...

The hospitality industry has always been a delicate balancing act between opportunity and risk, but when Covid-19 swept across the globe, it shook our industry to its very core, leaving even the ...

Our collective mission is to support the International Padel Federation elevate the sport on a global scale, and our world-class teams will work on a range of creative collaborations, initiatives and ...

Held every four years, the Global Refugee Forum is the world’s largest international gathering on refugees. It brings together UN Member States, non-governmental organizations, the private sector, ...

Victor Wembanyama has been ruled out for the rest of the NBA season with deep vein thrombosis in his right shoulder, the team announced Thursday. The shocking news will have a far-reaching impact on ...